View our publications

Read publications from the Muhitch Lab.

Read the research

Determining immunogenic vulnerabilities in kidney cancer 

The goal of the Muhitch lab is to elucidate the molecular mechanisms that limit renal cell carcinoma patient responses to immunotherapy. 

Our translational studies concentrate on enhancing anti-tumor immunity through improved myeloid cell function and cytolytic T cell activity within renal cell carcinoma.  

Meet the Team

Dr. Muhitch in a hallway

Research focus

T cell activity within kidney cancer patient tumors

See the science
Cell slide from a microscope

Publications

Check out the latest articles, abstracts, editorials, and more from the Muhitch lab.

Read the research

A scientist works at a lab bench with a person in a shark costume

People

Get to know the Muhitch lab’s principal investigator and research team.

Meet our team

In the news

Roswell Park Teams Draw More Than $34 Million in Grants Supporting New Research
Dr. Seshadri talking with a colleague
A Cancer Innovation Engine: 10 Roswell Park Research Advances to Look for in 2021
Image showing a breast tumor with infiltrating immune cells.
Deep Look at Immune Cells in Patients’ Tumors Reveals Insights on Timing for Treatment Combinations
Jason Muhitch, PhD
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer, Roswell Park Researchers Show
SBRT Paper - Schwaab, Singh, Muhitch

Faculty affiliations

Department of Immunology
The Department of Immunology at Roswell Park
Tumor Immunology & Immunotherapy Research Program
Scientist looking through a microscope
Tumor Immunology PhD Track
Tumor Immunology Program

Connect with the Muhitch Lab

Email: Jason.Muhitch@RoswellPark.org  

Department of Immunology
Roswell Park Comprehensive Cancer Center 
Elm and Carlton Streets 
Buffalo, NY 14263